CRA Approved $3.1 Billion in SR&ED Last Year. Here's What That Means for Your Claim.

The $3.1 billion most Canadian companies never touch

In the 2023–2024 fiscal year, the Canada Revenue Agency paid out approximately $3.1 billion in Scientific Research and Experimental Development (SR&ED) tax credits. That makes Canada's SR&ED program one of the largest R&D tax incentives in the world — larger than the UK's R&D Tax Relief, comparable to France's Crédit Impôt Recherche, and second only to the United States' R&D Tax Credit in absolute terms.

But here's the twist: most of that $3.1 billion goes to a surprisingly small number of claimants. Based on publicly available CRA information, thousands of Canadian corporations file SR&ED claims annually. The median claim is typically small — under $100K — but the distribution is heavily skewed. A small number of large claimants (primarily in aerospace, pharmaceuticals, and technology) capture a disproportionate share of the total.

What CRA's own data reveals about claim success

CRA publishes limited data on claim outcomes, but what is available tells a clear story. Claims with the following characteristics have significantly higher approval rates and lower reduction rates:

• Well-documented systematic investigation: claims with contemporaneous evidence (design documents, test logs, iteration records) face less scrutiny than claims based on reconstruction.
• Appropriate claim size for company scale: a $50K claim from a 5-person startup is less likely to be reviewed than a $500K claim from the same company — unless the $500K claim is clearly documented.
• Clear technological advancement narrative: claims that describe specific technical obstacles and systematic investigation receive more favourable treatment than claims that describe general product development.
• Software and technology claims: historically, software claims faced higher review rates than manufacturing or pharmaceutical claims. But software claims with proper documentation — especially those backed by version control, architecture records, and testing logs — now have comparable approval rates.

The 2024 federal budget made two changes that matter for tech companies: the enhanced ITC rate for CCPCs was maintained at 35% (it had been scheduled to drop), and the capital expenditure eligibility was expanded to include more cloud computing costs. Both changes benefit Canadian tech founders.

The industries that claim — and the ones that should

CRA's published data shows the top claiming industries: manufacturing, software, pharmaceuticals, and aerospace. But the growth industries — the ones building Canada's next generation of companies — are underrepresented:

• AI and machine learning companies: many don't realize that model architecture work, training pipeline development, and edge-case handling qualify when they require systematic investigation.
• Fintech and insurtech: algorithmic underwriting, fraud detection, and real-time risk scoring often involve genuine R&D that goes unclaimed.
• Cleantech and climate tech: the systematic investigation inherent in breakthrough environmental technology almost always qualifies.
• Healthtech and medical devices: clinical validation, algorithm development, and regulatory testing involve R&D that is often documented for FDA/Health Canada but not claimed for SR&ED.
• SaaS and B2B platforms: performance optimization at scale, novel architecture patterns, and integration challenges often qualify but are claimed as routine development.

How to join the group that gets approved

The path to a successful claim isn't mysterious. CRA publishes the criteria. The court decisions — from the foundational Northwest Hydraulic case to recent Federal Court rulings — have established clear precedent. The challenge is operational: building documentation habits that make the claim self-evident.

1. Start documenting in month one, not month twelve. Contemporaneous evidence is always stronger than reconstruction.
2. Focus on systematic investigation, not product features. CRA cares about how you solved the problem, not what the product does.
3. Quantify where possible. 'Reduced latency by 40%' is stronger than 'improved performance.'
4. Describe failures, not just successes. Dead ends demonstrate systematic investigation better than success stories alone.
5. Keep claim size proportionate to documentation quality. A small, well-documented claim is always better than a large, vague one.

The $3.1 billion program exists because Canada wants to incentivize R&D. The money is there. The question is whether your company is capturing its share.

Turn this guide into a claim package

SREDY.IO walks you through eligibility, project narratives, supporting costs, and evidence so your CPA has a cleaner file to review.

More guides

Ready to check if your work qualifies? Take the free eligibility assessment.